4th TGF-B Targeted Drug Development Summit
Evvnt Promotion / evvnt
Archive
15.10.2024 - 17.10.2024 The Clift Royal Sonesta San Francisco, 495 Geary Street, 94102 San Francisco, California, USA
Time: 9:00 AM - 5:00 PM
Conference themes
With 128 TGF-B targeted therapies in the clinic and 68 in the preclinical stage, the TGF-B field is currently being rejuvenated by novel approaches in immuno-oncology, and cutting edge research in fibrosis, autoimmune diseases, and beyond.
With 128 TGF-B targeted therapies in the clinic and 68 in the preclinical stage, the TGF-B field is currently being rejuvenated by novel approaches in immuno-oncology, and cutting edge research in fibrosis, autoimmune diseases, and beyond.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
URL:
Brochure: https://go.evvnt.com/2479168-3?pid=4832
Speakers: Alessandra Castiglioni, Senior Scientific Manager, Genentech, Anthony Conley, Associate Professor, MD Anderson Cancer Center, and more
URL:
Brochure: https://go.evvnt.com/2479168-3?pid=4832
Speakers: Alessandra Castiglioni, Senior Scientific Manager, Genentech, Anthony Conley, Associate Professor, MD Anderson Cancer Center, and more
Enquiries and Registration:
https://go.evvnt.com/2479168-2?pid=4832
Ms. Isabel Weir
General Medicine
Languages
English
English
Congress fees
USD 2199.00 - USD 4397.00
USD 2199.00 - USD 4397.00
Participants expected
1000 - 1000
1000 - 1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
